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Abstract: Colorectal cancer (CRC) cells undergo the remodeling of intracellular Ca2+ homeostasis,
which contributes to cancer hallmarks such as enhanced proliferation, invasion and survival.
Ca2+ remodeling includes critical changes in store-operated Ca2+ entry (SOCE) and Ca2+ store
content. Some changes have been investigated at the molecular level. However, since nearly 100 genes
are involved in intracellular Ca2+ transport, a comprehensive view of Ca2+ remodeling in CRC is
lacking. We have used Next Generation Sequencing (NGS) to investigate differences in expression of
77 selected gene transcripts involved in intracellular Ca2+ transport in CRC. To this end, mRNA from
normal human colonic NCM460 cells and human colon cancer HT29 cells was isolated and used
as a template for transcriptomic sequencing and expression analysis using Ion Torrent technology.
After data transformation and filtering, exploratory analysis revealed that both cell types were well
segregated. In addition, differential gene expression using R and bioconductor packages show
significant differences in expression of selected voltage-operated Ca2+ channels and store-operated
Ca2+ entry players, transient receptor potential (TRP) channels, Ca2+ release channels, Ca2+ pumps,
Na+/Ca2+ exchanger isoforms and genes involved in mitochondrial Ca2+ transport. These data
provide the first comprehensive transcriptomic analysis of Ca2+ remodeling in CRC.
Keywords: colorectal cancer; Ca2+ remodeling; transcriptomics; RNA-sequencing
1. Introduction
Ca2+ signaling is involved in the control of a large series of cell and physiological functions in
health and disease from exocytosis and muscle contraction to gene expression, cell proliferation,
migration and cell death [1]. Over the last few years, evidence has been accumulating that
dis-homeostasis of intracellular Ca2+ may be involved in many different disorders including
cancer [2,3]. In support of this view, several authors have reported that remodeling of Ca2+ signaling
in different forms of cancer contributes to cancer hallmarks, including exaggerated cell proliferation,
acquisition of cell migration and invasion capabilities, and enhanced resistance to cell death [2,3].
We have recently compared intracellular Ca2+ homeostasis in normal human colonic cells and human
colon carcinoma cells [4]. We found critical differences that may contribute to several of the above
cancer hallmarks. The most salient characteristics of Ca2+ remodeling in colon cancer cells relative to
their normal counterparts are the dramatic rise in store-operated Ca2+ entry (SOCE) and the partial
Int. J. Mol. Sci. 2017, 18, 922; doi:10.3390/ijms18050922 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2017, 18, 922 2 of 23
depletion of intracellular Ca2+ stores [4]. Enhanced entry of Ca2+ in colon cancer cells correlates
with enhanced cell proliferation and all SOCE antagonists tested and/or targeting molecular players
involved in this pathway result in inhibition of cell proliferation and cell migration [4–6]. In addition,
the partial depletion of Ca2+ stores provides resistance to cell death, probably because of impaired
mitochondrial Ca2+ overload and apoptosis [4–6].
SOCE, first reported by James W Putney in 1986 [7,8] is a ubiquitous Ca2+ entry pathway activated
after agonist-induced release of Ca2+ from intracellular stores at the endoplasmic reticulum (ER).
This is due to the opening of intracellular Ca2+ release channels gated by phospholipase C-dependent
synthesis of inositol trisphosphate IP3 receptors (IP3Rs) and/or Ca2+-induced Ca2+ release mediated
by ryanodine receptors (RYRs). At the molecular level, it is well established that Stromal Interaction
Molecules (STIM) sense ER Ca2+ levels. Emptying of Ca2+ stores promotes STIM oligomerization at
the ER endomembranes [9] and their interaction with cation channels in the plasma membrane of the
Orai1 [10] and transient receptor potential (TRP) families of Ca2+ channels [11]. Activation of SOCE
not only permits the refilling of Ca2+ stores but also promotes a sustained increase in intracellular Ca2+
concentration that is critical for the sustained activation of effector proteins including, for instance,
calcineurin and the ensuing activation of the nuclear factor of activated T cells [10].
After stimulation, the increased cytosolic free Ca2+ concentrations ([Ca2+]cyt) must return to
resting levels in the low nM range. This is achieved by systems that transport Ca2+ back from cytosol
to the extracellular space or into the ER against a large electrochemical gradient for Ca2+. This is
carried out by different adenosine triphosphate (ATP)ase Ca2+ pumps including plasma membrane
Ca2+ ATPases (PMCAs) [12], sarcoplasmic and/or endoplasmic reticulum Ca2+ ATPases (SERCAs) [13]
and the secretory pathway Ca2+ ATPases (SPCAs) [14]. An additional cotransporter, the Na+/Ca2+
exchanger, uses the passive transport of Na+ into the cell to extrude Ca2+ out of the cell [15]. Finally,
as has become increasingly evident in recent years, mitochondria contribute to clear Ca2+ loads
by means of the mitochondrial Ca2+ uniporter (MCU) and regulatory proteins [16]. In this case,
Ca2+ is transported down a huge electromotive force, the mitochondrial potential (∆Ψ) of about −180
mV, negative inside the mitochondrial matrix, that enables Ca2+ influx into mitochondria [17,18].
This potential is particularly high in cancer cells due to the Warburg effect, the metabolic signature
of cancer cells [19]. Interestingly, mitochondria are also involved in control of SOCE in different
cell types [20,21], including colorectal cancer cells [18,22] where, store-operated Ca2+ channels may
undergo slow, Ca2+-dependent inactivation unless this process is prevented by Ca2+ removal by
surrounding mitochondria [20,21].
Our recent analysis of Ca2+ remodeling in colon cancer cells revealed increased expression of
several molecular players involved in SOCE [4–6]. However, Ca2+ remodeling is complex and may
involve changes in expression and/or activity of hundreds of genes related to Ca2+ signaling [23],
with nearly 80 of them directly involved in Ca2+ transport across biological membranes. By taking
advantage of Next Generation Sequencing technologies, particularly RNA-sequencing (RNA-seq) by
Ion Torrent methodologies, we were able to study in detail intracellular Ca2+ homeostasis in NCM460
cells reflecting normal human colonic cells [24,25] and HT29 cells [26] representing human colorectal
cancer cells, to investigate, for the first time, the transcriptomics of Ca2+ remodeling in CRC. To this
end, mRNA was isolated from four independent cultures of NCM460 and four independent cultures
of HT29 cells to be used as templates for transcriptomic analysis of the selected 77 genes shown in
Table 1.
The gene transcripts studied include all ten voltage-operated Ca2+ channels (VOCCs);
all seven well-established players involved in SOCE; all 27 TRP channels; all six Ca2+ release
channels—including IP3 receptors and ryanodine receptor isoforms—all nine Ca2+ pumps including
PMCAs, SERCAs and SPCAs; the three Na+/Ca2+ exchanger isoforms; all known genes involved in
mitochondrial Ca2+ transport; and other related proteins. Clustering analysis segregated data in two
different cell populations and genes were segregated into six independent gene families according to
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expression behavior. Overall, we found that 30 genes are expressed differentially in CRC cells relative
to normal cells, thus providing a first comprehensive view of Ca2+ remodeling in CRC.
Table 1. Genes involved in calcium transport analyzed in this study pooled by gene families.
Gene Group Protein Name (Gene Name)
Voltage Operated
Calcium Channels
Cav1.1 (CACNA1S); Cav1.2 (CACNA1C); Cav1.3 (CACNA1D); Cav1.4 (CACNA1F);
Cav2.1 (CACNA1A); Cav2.2 (CACNA1B); Cav2.3 (CACNA1E); Cav3.1 (CACNA1G);
Cav3.2 (CACNA1H); Cav3.3 (CACNA1I)
Store-Operated
Calcium Entry Player Orai1; Orai2; Orai3; STIM1; STIM2; CRACR2A (EFCAB4B); MS4A12
TRP Channels
TRPC1; TRPC3; TRPC4; TRPC5; TRPC6; TRPC7; TRPV1; TRPV2; TRPV3; TRPV4;
TRPV5; TRPV6; TRPM1; TRPM2; TRPM3; TRPM4; TRPM5; TRPM6; TRPM7; TRPM8;
TRPA1; TRPML1 (MCOLN1); TRPML2 (MCOLN2); TRPML3 (MCOLN3);
TRPP1 (PKD2); TRPP2 (PKD2L1); TRPP3 (PKD2L2)
Calcium Release
Channels IP3R1 (ITPR1); IP3R3 (ITPR2); IP3R3 (ITPR3); RYR1; RYR2; RYR3
Calcium Pumps PMCA1 (ATP2B1); PMCA2 (ATP2B2); PMCA3 (ATP2B3); PMCA4 (ATP2B4); SERCA1(ATP2A1); SERCA2 (ATP2A2); SERCA3 (ATP2A3); SPCA1 (ATP2C1); SPCA2 (ATP2C2)
Sodium Calcium
Exchangers NCX1 (SLC8A1); NCX2 (SLC8A2); NCX3 (SLC8A3)
Mitochondrial Calcium
Transport Proteins
MCU; MICU1; MICU2 (EFHA1); MICU3 (EFHA2); MCUR1 (CCDC90A);
EMRE (C22orf32); MCUb (CCDC109B); VDAC1; VDAC2; VDAC3
Other Proteins Bcl-2 (BCL2); Calsequestrin 1 (CASQ1); Calsequestrin 2 (CASQ2); PICALM;Phospholamban (PLN)
Cav: Ca2+ channel; STIM: Stromal Interaction Molecules; TRPC: canonical TRP channels; TRPV: vaniloid family
of transient receptor potential channels; TRPM: melastatin family of transient receptor potential channels; TRPP:
polycystine family of transient receptor potential channels; IP3R: inositol trisphosphate receptors; RYR: ryanodine
receptors; PMCA: plasma membrane Ca2+ ATPases; SERCA: sarcoplasmic and/or endoplasmic reticulum Ca2+
ATPases; SPCA: secretory pathway Ca2+ ATPases; NCX: sodium-calcium exchanger; MCU: mitochondrial Ca2+
uniporter; EMRE: MCU regulator; VDAC: voltage-dependent anion channels; PICALM: phosphatidylinositol
binding clathrin assembly protein.
2. Results and Discussion
2.1. Data Set Transformation and Filtering
mRNA from four independent cultures of normal (NCM460) human colonic cells and four
independent cultures of human colorectal (HT29) cells were isolated and used as templates for
transcriptomic analysis of 77 genes involved in intracellular Ca2+ transport (Table 1) as detailed
in the Methods section.
RNA-seq data sets consist of aligned reads from gene fragmentations against a reference genome.
Accordingly, the longer a gene is, the higher the amount of fragments that come from it. In addition,
the longer the gene is, the more likely it is that one of the reads aligns against this gene. As we are
concerned with analyzing not only differential expression between normal and tumor cells, but also
with differential expression among genes of the same family, raw gene data was normalized for the
corresponding gene length (l) and the size of the library samples (n), thus making expression values
among different genes readily comparable. As expression values after normalization are very small,
they were multiplied by 109 to obtain expression values as Reads per Kilobase per Millions of mapped
reads (RPKM) that can be obtained using the following expression (1).
RPKM =
reads
l·n ·10
9 (1)
Another important issue relative to RNA-seq data sets is that they contain usually a large amount
of low and disparate values. Thus, it is very important to be careful with the scale employed. If we
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use a raw data set, almost all data will plot on low values and only a few on higher values, thus
occluding large parts of data (Figure 1A,B). This problem could affect techniques of Exploratory
Data Analysis such as Principal Components Analysis or Cluster Hierarchical Analysis, since highly
expressed genes could dominate them. To solve this issue, raw data has to be transformed numerically
using, for example, Box-Cox Transformations or Logarithmic Transformations. In the present study,
we used a data transformation similar to logarithmic transformation in base 2. Transformation shrinks
data variation across samples. However, low-expression genes tend to over-dominate when this
transformation is used. This is due, on one hand, to Poisson noise, related to low values of reads and, on
the other hand, to the fact that logarithm transformation amplifies differences among low values. Thus,
low-expression genes will show relatively larger differences among samples (Figure 1C,D). To solve
this problem, we have used Regularized Logarithm Transformation (rlog). In this case, the outcomes
of highly expressed genes are similar to outcomes obtained by logarithmic transformation in base two.
In addition, differences among low values essentially disappear (Figure 1E,F).
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[28], who suggested filtering out those genes that are not readily expressed in any of the samples and 
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profile is lower than 0.125 RPKM (Figure 2). Interestingly, three types of gene populations according 
Figure 1. Gene expression level data transformation. Raw data set values (A,B). Log2 transformation
(C,D); rlog transformation (E,F). RNA-seq: RNA-sequencing.
Another key point of RNA-seq data analysis is filtering in order to minimize hypothesis testing.
We have to take into account that RNA-seq data sets contain a large amount of values equal to zero,
since not all genes are expressed by every kind of cell, and that is very important relative to filtering.
Thus, those genes that may not play any role or show no relationship to phenotype may be removed
from the data expression set. Nevertheless, we need to be careful in this step to avoid removing genes
which marginally do not show any kind of activity in a cell but may act jointly with other genes. Thus,
we have considered taking into account the criteria set up by Hackett [27] and Seyednasrollah [28],
who suggested filtering out those genes that are not readily expressed in any of the samples and
whose median expression profile is lower than 0.125 RPKM [29]. Data transformed in this manner
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were filtered in order to remove those genes considered as non-expressed, whose median expression
profile is lower than 0.125 RPKM (Figure 2). Interestingly, three types of gene populations according to
expression values emerge after filtering: genes expressed at low, intermediate and high expression
levels (Figure 2).
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Figure 2. Gene expression level filtering. Histograms of data before (A) and after (B) the data set
filtration process. Filtering was carried out by removing genes with a profile expression lower than
0.125 Reads per Kilobase per Millions of mapped reads (RPKM). Data are shown as rlog transformed.
2.2. Exploratory Data Analysis: Hierarchical Clustering
After data transformation and filtration, two different exploratory data analyses were carried
out; although they are not hypothesis testing, they are useful for generating hypotheses. The first
one, known as Hierarchical Cluster Analysis, is carried out both in samples and genes. This analysis,
using Euclidean distance as dissimilarity measurement, allows the breaking up of samples or genes into
groups of members sharing common characteristics. It also establishes which genes are co-regulated.
The second exploratory data analysis is known as Principal Components Analysis, which is very useful
in order to reduce the dimension of the data or to find patterns among genes or samples, thus getting
new variables which are a linear combination of the original ones.
Hierarchical Clustering Analysis forms observation clusters whose members share common
characteristics. For example, it is possible to detect different populations, such as healthy and tumor
phenotypes, thereby clustering each sample into a healthy or tumor group. Furthermore, if the existence
of different groups is known, it could be possible to identify a rule to sort the observations. For example,
we can sort samples with Discriminant Analysis [30]. In the present study, we clustered both samples
and genes. Thus, if we classify samples, we can discover the different populations they came from
and, if we classify genes, we can use the information to carry out, for example, an Enrichment Gene
Set Analysis that identifies which gene clusters are related to the tumoral phenotype. However,
this analysis was not undertaken here because of the low number of genes studied and for the sake
of brevity.
We first carried out the Hierarchical Cluster Analysis considering the eight samples used as
observations and genes as variables. The dissimilarity measurement chosen is Euclidean distance,
and the analysis is shown as a heatmap with dendograms in both axes of Figure 3. According to
the map, it is clear that two groups have been formed, where the first one contains all four samples
belonging to the normal, healthy phenotype (A, B, C, D), and the second one contains all four samples
corresponding to the tumor phenotype (E, F ,G ,H) (Figure 3). The distance among samples belonging
to the same phenotype is much smaller than the distance among samples belonging to different
phenotypes. Each value represented in the heatmap corresponds with the distance between each
sample couple.
A second Hierarchical Clustering Analysis was carried out in a similar way, except that now the
77 genes are considered as observations and the eight samples as variables. The result of the analysis
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is shown in Figure 4. The Euclidian distances map shows that the 77 genes in the pool break into six
different groups. All the genes in each group behave similarly in the sense that, regardless of whether
they are high or low expressed in normal and tumor cells, expression levels are similar for all genes
within each group and different from expression levels of the other gene families according to the
Euclidian distances shown in Figure 4.Int. J. Mol. Sci. 2017, 18, 922  6 of 22 
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2.3. Gene Correlations
Next, we questioned possible correlations between gene couples. In this way, correlation values
for each gene couple were plotted in the heatmap shown in Figure 5. Thus, in the case that two
genes are positively and strongly correlated, if the expression of one of them is low in tumor samples,
the expression of the other one will also be low in the normal sample. Conversely, if the pair of
genes is negatively and strongly correlated and the expression of one of them is low in tu or samples,
the express on of the other one would be very high in normal cells (Figure 5). Thus, for correlated genes,
expression of one of them will allo prediction of the b havior of the correlated genes. For instance,
Int. J. Mol. Sci. 2017, 18, 922 7 of 23
MCU and MICU1 are very positively co-regulated with Orai2 and RYR1 and are thus extremely
and negatively co-regulated with RYR2. Thus, when the expression of MCU and MICU1 increases,
the expression of Orai2 and RYR1 will be also high, whereas the expression of RYR2 would be much
lower. Nevertheless, not all genes are co-regulated, either positively or negatively, and there are many
genes that are not co-regulated. For example, MCU and MICU1 do not co-regulate with ATP2A3,
and they are almost uncorrelated with TRPM3 and TRPM4. Therefore, while the expression of MICU1
and MCU is enhanced in the tumor phenotype, the expression of ATP2A3, TRPM3 and TRPM4 seems
not to vary much. Therefore, this analysis enabled us to uncover which genes behave in the same way
and which do not when comparing healthy and tumor phenotypes. In addition, it can predict whether
or not the behaviors are similar.
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Figure 5. Correlation or co-regulation between couples of genes. The larger the circle and the darker the
color, the higher the correlation (either positive in blue or negative in red) between each pair of genes.
2.4. Principal Component Analysis
The Principal Component Analysis describes the variation produced by a multivariate observation,
such that new variables are made from linear combinations of the original variables. These new
variables are known as Principal Components (PCs). Thus, if the observation has p original variables,
up to p PCs can be made, hich are sorted by the amount of explained variance by each of them,
where PC1 explains the largest amount of variance, followed by PC2, and so on. Therefore, this analysis
is intended to reduce the dimension of the observations. With the new dimensions selected, PCs explain
the largest possible amount of variance. Indeed, a criterion for deciding how many PCs to keep is that
the proportion of variance explained for all PCs selected is larger than 70%. Other criteria are taken
from the Decay graph, which represents the explained variance by each PC against the corresponding
PC. Thus, the number of PCs located in the Decay graph before the slope of the graph changes
drastically (Figure 6) shows that the variance explained does not increase much despite considering
more PCs.
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As it is really difficult for multivariate data to verify the assumption that they fit a normal
distribution, the Principal Component Analysis is considered as a kind of exploratory data analysis.
This is why data have been filtered and transformed previously—to fit normal distribution as much as
possible. Furthermore, data have been centered with their mean, and standardized with their variance.
I t pr sent stu y, a Principal Component Analysis between samples as a function of the
expression profile of p genes has been carried out and the r sults are shown in Figure 6. We found
that PC1 clearly explains the difference between phenotypes, since the projections of the values for
each sample over PC1 show how the samples belong to a healthy phenotype and are well separated
from the samples belonging to the tumor phenotype. Since the variance explained by PC1 is 59.82%,
and the one explained by the two first PCs is 76.79%, together with the fact that the slope of the Decay
graph changes drastically from PC2, it is a good decision to keep only the first two PCs.
Given that PC1 clearly reproduces the two different groups related with the phenotype, it is
interesting to evaluate the influence of each original variable gene, which is proportional to a coefficient
associated with the linear combination for each gene. The way in which this is evaluated in the present
study is by estimating the correlation between each gene and PC1. Genes with correlations larger than
|0.7| are shown in Table 2.
Accordingly, it is possible to obtain the following expression (2):
PC1 =
p
∑
i = 1
rlog(expression o f gene.i)·βgene.i (2)
where PC1 is the value of the Principal Component 1, rlog(expression of gene.i) is the value of expression
for each gene after transformation (see supplementary data for raw expression data of individual
genes) and βgene.i is the coefficient value for the same gene (Table 2). This enables the sorting of
a given sample to the normal or tumor phenotype. It is important to take into account that the values
of the original variables have been transformed, centered and standardized as reported.
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Table 2. Coefficient values from Principal Component (PC1) corresponding to each gene. Raw data were transformed, filtered, centered and standardized. To obtain
PC1 value for a given sample, use coefficients in this table in expression 2.
Gene Expression Gene Expression Gene Expression Gene Expression Gene Expression
ATP2A1 −0.166 CACNA1C −0.174 ITPR1 0.143 ORAI3 0.090 TRPA1 −0.147
ATP2A2 0.148 CACNA1D 0.162 ITPR2 −0.173 PICALM −0.089 TRPM3 −0.070
ATP2A3 −0.088 CACNA1G 0.072 ITPR3 0.152 PKD2 0.020 TRPM4 −0.113
ATP2B1 0.172 CACNA1H −0.173 MCOLN1 −0.175 PKD2L1 −0.169 TRPM5 −0.168
ATP2B4 −0.173 CACNA1I −0.084 MCOLN2 −0.174 RYR1 0.103 TRPM7 0.105
ATP2C1 −0.121 CASQ1 0.093 MCOLN3 −0.148 RYR2 −0.174 TRPV1 −0.141
ATP2C2 0.142 CCDC109B −0.167 MCU 0.149 SLC8A1 −0.010 TRPV2 0.096
BCL2 −0.141 CCDC90A 0.140 MICU1 0.131 SLC8A2 0.165 TRPV3 −0.060
C22orf32 0.131 EFCAB4B −0.169 ORAI1 0.061 STIM1 0.174 TRPV4 0.026
CACNA1B −0.141 EFHA1 −0.149 ORAI2 0.168 STIM2 0.057 TRPV6 0.133
VDAC1 −0.175 VDAC2 0.147 VDAC3 −0.170 TRPC1 0.041
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2.5. Differential Expression Analysis
There is no consensus on the best way to carry out a Differential Expression Analysis. It is also
debatable which methods perform best as well as which probability distribution fits best to a given
data set [28,31]. In the present study, a data set shows a low sequencing depth, unbalanced sequencing
depth among samples, and low number of technical replicates (n = 4). In order to keep a relatively
conservative approach and, at the same time, identify a good number of genes differentially expressed,
three different methods were used: EdgeR [32], DESeq2 [33] and Limma [34]. EdgeR is the less
conservative method because it detects the largest number of true positives (genes which are indeed
expressed differentially) at the expense of introducing more false positives. In contrast, DESeq2 is
considered the most conservative one [31]. Thus, Zhang et al. [31] recommend using EdgeR when the
experimental design is unbalanced and sequencing depth and number of replicates are low. However,
Seyednasrollah [28] suggests using Limma because of its good documentation and speed, as well as
ease of use and robustness. Thus, we followed the suggestion by Zhang et al. [31] of taking the genes
differentially expressed which belong to the intersection from these three methods in order to avoid
a high amount of false positives. Accordingly, we used an R/Bioconductor package called Enrichment
Browser [35], and applied Limma, EdgeR and DESeq2 methods of differential expression analysis.
Only those genes whose differential expression was considered significant by all three independent
methods were considered to be expressed differentially. Table 3 shows fold changes for all 30 considered
differentially expressed genes out of the 77 analyzed, along with the three p values obtained by the
three independent methods. We found that 12 genes were significantly upregulated in CRC cells
(positive fold change) while the remaining 18 genes were significantly downregulated (negative fold
change). The most robust changes corresponded to the transient receptor potential channel, vaniloid 6
(TRPV6) and the sodium-calcium exchanger 2 (NCX2) for upregulated genes in CRC, and ryanodine
receptor 2 (RyR2) and voltage-dependent Ca2+ channel 1.2 (Cav1.2) for downregulated genes. In order
to appreciate best the differential gene expression, changes corresponding to each family of genes are
detailed next.
Table 3. Differential gene expression fold change. Fold changes are expressed as
   i. , ,  1  2 
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ATP2B1 1.66289207 1.32 × 10−29 1.69 × 10−13 1.58 × 10−5 
ATP2B4 2.75628322 5.53 × 10-18 7.86 × 10−22 3.01 × 10−6 
BCL2 2.34849379 0.00307301 0.00070215 0.00754796 
CACNA1B 2.19132122 0.00190951 0.00050421 0.00207432 
CACNA1C −11.408836 1.05 × 10−24 1.40 × 10−53 1.24 × 10−9 
CACNA1D 1.55721384 1.97 × 10−08 9.80 × 10−06 0.00077412 
CACNA1H −4.7419621 2.25 × 10−29 1.04 × 10−17 3.37 × 10−6 
CCDC109B 2.08593613 4.67 × 10−8 2.73 × 10−09 0.00018476 
EFCAB4B 2.03186213 4.66 × 10−11 1.96 × 10−14 4.98 × 10−5 
EFHA1 0.74675824 0.00147429 0.00014479 0.00278932 
ITPR1 0.83887283 3.72 × 10−5 0.00927132 0.00956689 
ITPR2 1.76953569 4.12 × 10−46 5.79 × 10−21 3.01 × 10−6 
ITPR3 0.52236077 3.25 × 10−5 0.0068986 0.01284295 
MCOLN1 1.79737402 8.88 × 10−82 2.08 × 10−17 8.54 × 10−7 
MCU 0.73588616 6.87 × 10−8 0.00151019 0.00278932 
MICU1 0.50129943 0.00011815 0.02325149 0.01284295 
ORAI2 2.15394804 4.74 × 10−15 3.48 × 10−14 0.00018476 
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ITPR2 1.76953569 4.12 × 10−46 5.79 × 10−21 3.01 × 10−6
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Table 3. Cont.
p-Value Adjusted by BH Method
ID Fold Change BH.DESeq2 BH.edgeR BH.limma
PKD2L1 5.34354792 1.49 × 10−8 2.43 × 10−10 3.01 × 10−6
RYR2 12.5085599 1.17 × 10−30 1.39 × 10−77 2.95 × 10−10
SLC8A2 4.76101144 2.08 × 10−15 1.17 × 10−14 0.00010438
STIM1 1.92340546 5.41 × 10−70 1.20 × 10−23 1.80 × 10−6
TRPA1 −7.2445088 9.71 × 10−8 4.32 × 10−10 3.59 × 10−6
TRPM5 1.57085974 7.99 × 10−6 0.00121578 0.00097882
TRPV6 3.55456363 7.99 × 10−6 1.29 × 10−6 0.02627047
VDAC1 1.70533848 1.03 × 10−75 1.02 × 10−39 1.03 × 10−8
VDAC2 0.32791712 0.00017495 0.035753 0.00617185
VDAC3 1.50237461 6.80 × 10−10 1.07 × 10−14 5.86 × 10−6
Expression levels for all ten voltage-operated Ca2+ channels (VOCCs) are shown in Figure 7.
This family is formed by three subfamilies named Cav1, Cav2 and Cav3. Although epithelial colonic
cells are not electrically excitable cells and lack functional voltage-operated Ca2+ entry, both normal
and colon cancer cells express mRNAs for some VOCCs. Cav1.1 to Cav1.4 are L-type VOCCs sensitive
to dihydropyridines. Only Cav1.3 is expressed in both normal colonic and colon cancer cells and
expression levels are significantly enhanced in tumor cells (Figure 7A). Cav1.2 is expressed only in
normal cells and the remaining Cav1.1 and Cav1.4 are missing in both cell types (Figure 7A).
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The second subfamily of VOCCs, Cav2s, include P/Q and R type channels typically restricted to
neurons. Only Cav2.2 is expressed in normal colonic cells and expression is essentially lost in CRC
cells (Figure 7B).
Finally, Cav3.1 to Cav3.3 are T-type Ca2+ channels activated only at high potentials and expressed
typically in cardiac and smooth muscles as well as in some neurons. Only Cav3.2 is expressed in
normal colonic cells and expression is also nearly lost in CRC cells (Figure 7C). Interestingly, it has
been shown recently that blockers of T-type channels may prevent colon cancer growth [36]. Thus,
transcripts of Cav1.2, Ca1.3, Cav2.2 and Ca3.2 are differentially expressed in normal colonic and CRC
cells. In any case, we must take into account that expression of these channels at the protein level may
or may not correlate with expression at the messenger level.
Gene expression levels for molecular players involved in SOCE are shown in Figure 8.
Store-operated Ca2+ entry, also named capacitative Ca2+ entry, is activated after agonist-induced
emptying of intracellular Ca2+ stores. This pathway is mediated by interactions between STIM sensors
at the ER and Orai channels at the plasma membrane. All three Orais are expressed in both normal
and colon cancer cells and expression appears to be increased for all of them (Figure 8A). However,
only differences for Orai2 mRNA are significant in tumor cells (Figure 8A). STIM and 2 are also
expressed in normal and colon cancer cells (Figure 8B). Interestingly, STIM1 is significantly enhanced
in tumor cells, whereas STIM2 remains similar (Figure 8). In addition to these players, MS4A12 has been
reported to be a colon-selective store-operated Ca2+ channel promoting malignant cell processes [37].
However, MS4A12 mRNA is barely or not expressed either in normal cells and CRC cells (Figure 8C).
Finally, CRACR2A, a SOCE regulatory protein [38], is expressed in both normal and tumor cells and
expression levels are diminished in tumor cells (Figure 8D).
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(TRPCs). There are seven members of the TRPC family of cation channels TRPC1 to TRPC7. RNA-
seq data shows that both colonic and CRC cells express only TRPC1 and expression seems increased 
in colon cancer cells. However, difference is not significant (Figure 9A). These results are at variance 
with our previous results using quantitative reverse transcription-polymerase chain reaction (qRT-
PCR) [4]. Differences could be explained by increased sensitivity and/or threshold for significance in 
our present analysis. In any case, we have confirmed that expression of TRPC1 protein is significantly 
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We have assessed differential gene expression of all 27 human TRP channels (Figure 9).
TRP channels ar cationic channels t at may permeate Ca2+ with variable selectivity and are i volved
in disparate cell functions, some of them contribut ng to SOCE, particularly the canonical TRP
channels (TRPCs). T ere are seven members of the TRPC family of cation channel TRPC1 to TRPC7.
RNA-seq data shows that both colonic and CRC cells express only TRPC1 and expression seems
increased in colon cancer cells. However, difference is not significant (Figure 9A). These results
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are at variance with our previous results using quantitative reverse transcription-polymerase chain
reaction (qRT-PCR) [4]. Differences could be explained by increased sensitivity and/or threshold for
significance in our present analysis. In any case, we have confirmed that expression of TRPC1 protein
is significantly enhanced in CRC [4], stressing further the need for protein and functional confirmation
of transcriptomic/genetic analysis.
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Expression levels of canonical transient receptor potential channels TRPCs (A), canonical Transient
Receptor Potential channels (TRPVs) (B), Melastatin Transient Receptor Potential channels (TRPMs) (C),
Mucolipin Transient Receptor Potential channels (TRPMLs) (D), Polycystin Transient Receptor Potential
channels (TRPPs) (E) and Transient Receptor Potential channel member A, subfamily 1 (TRPA1) (F) in
normal colonic cells (grey bars) and colon cancer cells (red bars). * p statistically significant by three
independent methods.
The vaniloid family of transient receptor potential channels (TRPVs) are a very heterogeneous
family of six cationic channels from TRPV1 to TRPV6. Only TRPV1, TRPV3 and TRPV6 are expressed
in colonic cells. Interestingly, while expression levels of TRPV1 and TRPV3 are similar in normal
and CRC cells, TRPV6 is significantly enhanced in tumor cells (Figure 9B). This channel is involved
in vitamin D-dependent absorption of extracellular Ca2+ in the intestines. Interestingly, it has been
previously reported that TRPV6 is overexpressed in prostate cancer [2,3].
The mela tati family of transient receptor potential channels (TRPMs) are a big family of eight
cation channels from TRPM1 t T 8. Only three o them, TRPM4, TRPM5 and TRPM7, appear to
be expressed in colonic cells. Levels of TRPM4 and TRPM7 are similar in normal colonic and CRC
cells. However, expression of TRPM5 decreases significantly in CRC cells (Figure 9C).
The mucolipin family of transient receptor potential channel (TRPMLs) are a family of three
channels, TRPML1 to 3, also named mucolipins. Only the two first mucolipines are expressed in
Int. J. Mol. Sci. 2017, 18, 922 14 of 23
normal and tumor cells and both are significantly decreased in CRC cells. Particularly noteworthy is
the case of TRPML2 that is dramatically downregulated in colon cancer cells (Figure 9D).
The polycystine family of transient receptor potential channels (TRPPs) are also a family of three
channels, TRPP1 to TRPP3, TRPP1 being the best known for its role in polycystic kidney disease.
TRPP1 is expressed in both normal and colon cancer cells to the same extent (Figure 9E). TRPP2 is
expressed only in normal cells (Figure 9E) and TRPP3 is absent in both normal and colon cancer cells
(Figure 9E).
Finally, the transient receptor potential channel, member A, subfamily 1 (TRPA1), a stress sensor
and only member of the TRPA family of channels, is expressed in normal colonic cells but not in colon
cancer cells (Figure 9F).
In summary, only 11 out of the 27 TRPs are expressed in colonic cells, either normal or tumor.
In addition, only six show differential expression. In all the cases but one, TRP channels are
downregulated in CRC cells relative to normal cells, TRPV6 being the only TRP channel significantly
increased in CRC cells. Functional consequences of changes in expression of TRP channels in CRC
remain to be established.
Expression of Ca2+ release channels is shown in Figure 10. IP3 and ryanodine receptors are Ca2+
release channels at the ER, the most important intracellular Ca2+ store. There are three IP3 receptor
(IP3R) subtypes, IP3R1 to IP3R3, and all of them are expressed in both normal colonic and colon cancer
cells (Figure 10A). Interestingly, all three isoforms are also differentially expressed in colon cancer cells
relative to normal cells. While genes corresponding to IP3R1 and IP3R3 are overexpressed in colon
cancer cells, gene coding for IP3R2 is downregulated (Figure 10A). Interestingly, consistent with these
results, it has been reported that the type III IP3R is absent in normal colonic cells but is expressed
in colon cancer. Moreover, expression levels are directly related to aggressiveness of the tumor [39].
In addition, it has been also reported that depletion of mutated K-Ras in a colon cancer cell line
changes Ca2+ store content and susceptibility to apoptosis by promoting changes in expression of IP3R
isoforms [40]. Therefore, IP3Rs are critical players in Ca2+ remodeling in colon cancer, contributing
likely to changes in Ca2+ store content and susceptibility to apoptosis.
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Figure 10. Expression of Ca2+ release channels in normal and colon cancer cells. Expression levels of
inositol trisphosphate receptors (IP3Rs) (A) and ryanodine receptors (RyRs) (B) in normal colonic cells
(grey bars) and colon cancer cells (red bars). * p statistically significant by three independent methods.
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Regarding RyRs, only genes coding for RyR1 and 2 are expressed in colonic cells, although RyR2
is by far the most abundant isoform (Figure 10B). In addition, RyR2 is dramatically downregulated in
colon cancer cells (Figure 10B). Together, these data indicate that Ca2+ release could be substantially
influenced in CRC cells relative to normal cells as reported recently [4].
Gene expression levels for Ca2+ pumps including PMCAs, SERCAs and SPCAs are shown in
Figure 11. Regarding genes coding for PMCAs, we found that only PMCA1 and PMCA4 are expressed
in both normal and colon cancer cells, while PMCA2 and PMCA3 are absent in both cell types
(Figure 11A). Interestingly, PMCA1 expression increases in cancer cells while expression of PMCA4
is downregulated in tumor cells (Figure 11A). Thus, data suggest a molecular switch from PMCA4
to PMCA1 in CRC. These results are consistent with a previous report showing that undifferentiated
colonic cell lines express PMCA1 and differentiation downregulates it while promoting expression of
PMCA4 [41].
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Figure 11. Expression of Ca2+ pumps in normal and colon cancer cells. Expression levels of plasma
membrane Ca ATPases (P CAs) (A), sarcoplasmic and/or endoplasmic reticulum Ca ATPases
(SERCAs) (B) and secretory pathway Ca2+ ATPases (SPCAs) (C) in normal colonic cells (grey bars) and
colon cancer cells (red bars). * p statistically significant by three independent methods.
All three SERCAs are also expressed in both normal and tumor cells (Figure 11B). Interestingly,
SERCA1 expression decreases significantly in tumor cells while SERCA2 is upregulated in tumor cells.
No difference is observed in SERCA3 (Figure 11B). Thus, a molecular switch from SERCA1 to SERCA2
may be also involved in CRC. Finally, both SPCAs are expressed in normal and colon cancer cells but
expression levels are similar (Figure 11C). Although SPCA2 seems to be overexpressed in cancer cells,
differences were significant by only two of the three methods used to assess significance. Changes
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in SERCA activity could lead to possible differences in Ca2+ store content between normal and CRC
cells. In fact, we have reported recently that CRC cells display the partial depletion of Ca2+ stores [4].
This effect has been partially attributed to loss of ER Ca2+ sensor STIM2 [4]. Whether changes in
SERCA isoform contribute to this remodeling as well remains to be established.
Expression of Na+/Ca2+ exchanger isoforms is shown in Figure 12. These co-transporters normally
extrude Ca2+ back to the external medium in exchange for Na+ using the electrochemically favorable
gradient for Na+. There are three isoforms named NCX1, NCX2 and NCX3, but only NCX1 and NCX2
are expressed in normal and colon cancer cells. Interestingly, while expression of NCX1 is similar in
normal and CRC cells, expression of NCX2 is dramatically enhanced in CRC cells, actually showing
the largest fold increase in expression in tumor cells of all upregulated genes tested (Figure 12).
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Gene expression levels for molecular players involved in mitochondrial Ca2+ transport are shown
in Figure 13. Ca2+ enters mitochondria down its electrochemical gradient through the mitochondrial
Ca2+ uniporter (MCU) that is modulated by several regulatory proteins including mitochondrial Ca2+
uptake (MICU) isoforms 1 to 3, mitochondrial calcium uniporter regulator 1 (MICUR1), mitochondrial
calcium uniporter dominant negative beta (MCUb) and MCU regulator (EMRE). Voltage-dependent
anion channels (VDAC) 1 to 3 in the outer mitochondrial membrane have been involved in apoptosis.
Interestingly, messengers involved in mitochondrial Ca2+ transport are very highly expressed in both
normal and CRC cells (Figure 13). In addition, all genes but MICU3 are expressed in both normal and
tumor cells (Figure 13). Expression of the channel MCU and its positive modulator MICU1 is enhanced
in tumor cells (Figure 13A,B), while expression of negative modulator MICU2 is decreased. Expression
of other MCU modulators including MICUR1 and EMRE is similar (Figure 13B,C,E), while MCUb is
significantly downregulated in colon cancer cells (Figure 13D). Finally, all three VDACs are expressed
at very high levels in both normal and tumor cells (Figure 13F). Interestingly, expression of all of them
is significantly different in colon cancer cells. VDAC1 and 3 are downregulated in colon cancer cells
while VDAC2 is significantly overexpressed in cancer cells.
Finally, expression of other related proteins is shown in Figure 14. Bcl-2 modulates Ca2+ release
and apoptosis. This gene is significantly downregulated in cancer cells (Figure 14) while expression
of two other proteins including calsequestrin 1 and phosphatidylinositol binding clathrin assembly
protein (PICALM), is similar (Figure 14B,C). No expression of calsequestrin2 and phospholamban is
observed in normal and colon cancer cells.
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Figure 14. Expression of selected genes coding for other selected proteins. Expression levels of BCL2, 
(A) calsequestrins CASQ1 and CASQ2 (B), PICALM (C) and PLN (Phospholamban) (D) in normal 
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Figure 13. Expression of genes involved in mitochondrial Ca2+ transport in normal and colon cancer
cells. Expression levels of Mitochondrial Calcium Uniporter (MCU) (A), Mitochondrial Calcium
Uptake (MICU) isoforms (B), Mitochondrial Calcium Uptake Regulator 1 (MICUR1) (C), Mitochondrial
Calcium Uniporter Dominant Negative Beta Subunit (MCUb) (D), Essential MCU regulator (EMRE)
(E) and voltage-dependent anion channels (VDACs) (F) in normal colonic cells (grey bars) and colon
cancer cells (red bars). * p statistically significant by three independent methods.
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Figure 14. Expression f selected genes coding f r other selected proteins. Expression levels of
BCL2, (A) calsequestrins CASQ1 and CASQ2 (B), PICALM (C) and PLN (Phospholamban) (D) in
normal colonic cells (grey bars) and colon cancer cells (red bars). * p statistically significant by three
independent methods.
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Changes in expression of all significantly expressed transcripts are shown in Figure 15A. To best
appreciate the differences, all genes that are significantly downregulated in tumor cells are removed
for the genes shown in normal cells (Figure 15B) but show up in the tumor cell (Figure 15C).
In summary, we report here a comprehensive transcriptomic analysis of Ca2+ remodeling in
colorectal cancer cells. A similar analysis has been recently carried out in glioblastoma using data
gathered from repository data sets of a large series of glioblastomas [23]. Data shown here were
generated using Ion Torrent RNA-sequencing from mRNA isolated from normal human colonic
NCM460 cells and colon cancer HT29 cells. Therefore, while the study has the limitation that both cell
lines may not reflect entirely normal human colonic and colon cancer cells, respectively, it does profit
from the fact that changes in intracellular Ca2+ handling between the two cell lines have been analyzed
in detail [4]. The results provide a strong molecular basis for Ca2+ remodeling in CRC.
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downregulated in cancer cells have been removed in the prototypical, normal colonic cell (B), whereas 
only genes upregulated in CRC are shown in the prototypic CRC cell (C). Molecular players in red 
are those with the largest fold changes in expression from the normal to the tumor phenotype. 
PMCAs, plasma membrane calcium ATPases; VOCCS, voltage-operated calcium channels; SOCE, 
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Figure 15. Molecular players differentially expressed in NCM460 normal colonic and HT29 colorectal
cancer cells. Genes significantly upregulated (↑) and downregulated (↓) in colorectal cancer cells vs.
normal colonic cells are shown in specific locations in the plasma membrane, the endoplasmic reticulum
(ER) and mitochondria (A). To best appreciate the differences, molecular players downregulated in
cancer cells have been removed in the prototypical, normal colonic cell (B), whereas only genes
upregulated in CRC are shown in the prototypic CRC cell (C). Molecular players in red are those
with the largest fold changes in expression from the normal to the tumor phenotype. PMCAs,
plasma membrane calcium ATPases; VOCCS, voltage-operated calcium channels; SOCE, store-operated
calcium entry; TRPs, Transient Receptor Potential channels.
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3. Materials and Methods
3.1. Materials
HT29 cells were donated by José Carlos Fernández-Checa (CSIC, Barcelona, Spain). NCM460
cells were obtained after a material transfer agreement with INCELL Corporation (San Antonio, TX,
USA). Dulbecco’s Modified Eagle’s Medium (DMEM), penicillin, streptomycin, L-glutamine and fetal
bovine serum came from Lonza (Basel, Switzerland). M3:10TM medium is from INCELL Corporation,
San Antonio, TX, USA).
3.2. Cell Culture
Cells are cultured in DMEM 1 g/L glucose or in M3:10TM medium as reported previously [4] and
supplemented with 1% penicillin-streptomycin, 1% L-glutamine and 10% fetal bovine serum. Cells are
maintained in standard conditions (37 ◦C, 10% CO2) and cultured once a week. All cells were used at
passages 3 to 10.
3.3. mRNA Isolation and Ion Torrent Reading
Total cellular RNA was isolated from NCM460 and HT29 cells using Trizol reagent (Invitrogen,
Carlsbad, CA, USA). Four totally independent samples from each cell line were used for molecular
analysis. Extracted RNA integrity was tested by electrophoresis on agarose gels and the purity and
concentration were determined by spectrophotometry. RNA was reverse transcribed using a High
Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Waltham, MA, USA) and the
cDNA diluted prior to PCR amplification. A targeted, multiplex PCR primer panel was designed using
the custom Ion Ampliseq Designer v1.2 (Thermo Fisher Scientific), where target regions were selected
for 77 genes directly or indirectly involved in Ca2+ transport and listed in Table 1. The panel was
designed to amplify PCR products appropriate for use with RNA from eight different cellular cultures,
where four of them belonged to one cellular line and the other four to another. Sequencing libraries
were prepared with Ion AmpliSeq RNA Library kit (Thermo Fisher Scientific) using the custom
primers. After primer digestion, adapters and Ion Xpress Barcode Adapters (Thermo Fisher Scientific)
were ligated to the amplicons followed by magnetic bead purification. Amplicon size and DNA
concentration were measured using an Agilent High Sensitivity DNA Kit (Agilent Technologies,
Santa Clara, CA, USA) according to the manufacturer’s recommendation. A total of eight picomols
of each of the eight samples were pooled for emulsion PCR (ePCR) on Ion Sphere Particles (ISPs)
using the Ion PGM Hi-Q OT2 Kit (Thermo Fisher Scientific) using the Ion OneTouch 2 Instrument.
Following automated Ion OneTouch, enrichment of template-positive ISP samples were loaded on
an Ion 316 V2 Chip and sequenced on a Personal Genome Machine (PGM-Thermo Fisher Scientific)
System with Ion PGM Hi-Q Sequencing Kit (Thermo Fisher Scientific). Raw sequencing reads were
initially filtered for high quality reads, and the adaptors were removed using the Ion Torrent Suite 4.4.3;
reads were then aligned with the hg19_rna reference sequence by TMAP [42] using default parameters.
Resulting binary format files (BAM) storing sequence data were processed through an in-house quality
control (QC) filter in order to keep those reads whose quality is larger or equal than Q20 and remove
polyclonal and primer dimers. After that, outcomes show that 253 Mbp were amplified: the length read
median is 108 bp. Reads were aligned against hg19_rna reference genome using GATK LeftAlignIndels
module, for 77 genes of interest, where average coverage was 93%, and mean raw accuracy was 99.3%.
BAM files were aligned. Amplicon primers were trimmed from aligned reads by Torrent Suite 4.4.3.
3.4. Transformation and Filtration of Raw Data Set
Raw data were transformed with an R/Bioconductor package called DESeq2 [33], applying rlog
function on data, and normalized against their gene length, obtained from R package EDASeq [43].
The R code used and the raw data employed in this study is provided as a supplementary file
data (esetCalcium file) so that anyone can reproduce the results. Subsequently, using R software,
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the transformed data set was filtered in order to remove those genes that are not expressed by samples;
thus genes whose median of expression profile was lower than 0.125 RPKMs were removed [29].
3.5. Exploratory Data Analysis
A transformed and filtered data set was analyzed through Exploratory Data Analysis. At first, for
both samples and genes, a Hierarchical Clustering Analysis using the Euclidean distance was carried
out as well as a correlation between different genes, using R software and stats, heatmap [44] and
Corrplot [45] R packages. A second method, the Principal Components Analysis, was applied in order
to reveal patterns and reduce the dimensionality of the data, using R software and stats, EDASeq [43]
and IRanges R packages.
3.6. Differential Expression Analysis
In order to carry out a differential expression analysis, three different methods were used to assess
significance. These methods are EdgeR [32], DESeq2 [33] and Limma [34], and they were implemented
using R software and EnrichmentBrowser R package [35] because this package allows the performing
of differential expression analyses either based on Limma, EdgeR or DESeq2, and adjusted p value
using the Benjamini-Hochberg method [46]. A critical issue is normalization of data. We have used
the default method of normalization in each package as suggested by Seyednasrollah [27] which has
a low influence on the analysis outcomes. In addition, we have controlled False Discovery Rate (FDR),
proposed by Benjamini-Hochberg [46] where the percent of false positives among whole test where
null hypothesis has been rejected is controlled.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/5/922/s1.
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Abbreviations
CRC Colorectal cancer
VOCC Voltage-operated Ca2+ channels
SOCE Store-operated Ca2+ entry
TRP Transient receptor potential channels
IP3R Inositol trisphosphate receptor
RyR Ryanodine receptor
PMCA Plasma membrane Ca2+/ATPase
SERCA Sarcoplasmic and endoplasmic reticulum Ca2+/ATPase
SPCA Secretory pathway Ca2+/ATPase
MCU Mitochondrial calcium uniporter
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